Jakub Kamiński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jakub Kamiński has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Marcin Narloch
University Clinical Hospital No. 4 in Lublin, Lublin, Poland
4 shared publications - Stanisław Kasprzak
Medical University of Lublin
4 shared publications - Karolina Kasprzak
1st Military Clinical Hospital with the Outpatient Clinic, Lublin, Poland
3 shared publications - Klaudia Klimczak
Medical University of Lublin
3 shared publications - Laura Loryś
Medical University of Lublin
3 shared publications - Izabela Kopeć
Medical University of Lublin
2 shared publications
Latest Publications
- Open Access
- 20 August 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
OBESITY DISEASE - NON-SURGICAL TREATMENT METHODS - A LITERATURE REVIEW
Introduction: Obesity, a global health crisis, is a leading risk factor for chronic diseases like diabetes and cardiovascular disease. Its prevalence has more than doubled since 1990, straining healthcare systems. Management involves primary prevention (lifestyle interventions), secondary prevention (early detection and treatment), and tertiary prevention (managing established obesity via lifestyle changes, pharmacotherapy, or bariatric surgery). This review focuses on non-invasive treatment methods for obesity. Materials and methods: This review was conducted using PubMed and Google Scholar databases, focusing on recent systematic reviews, meta-analyses, and original research on non-surgical obesity treatments. Keywords included obesity, diet, exercise, pharmacotherapy, and education. Results: Recent findings suggest that combining reduced calorie intake with limited carbohydrate consumption can lead to more effective weight loss. Diets high in protein, particularly those containing whey, are beneficial for maintaining muscle mass during weight reduction. Medications such as GLP-1 receptor agonists support weight loss and metabolic health. Regular physical activity enhances fat loss and cardiovascular performance. Additionally, patient-focused strategies are essential for improving adherence and ensuring long-term success in obesity treatment. Conclusions: Effective obesity treatment requires combining personalized nutrition plan, physical activity, and medications. Prioritizing muscle preservation, protein intake, patient education, and stigma reduction enhances adherence and supports long-term weight and metabolic health outcomes.
- 20 August 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
Open AccessOBESITY DISEASE - NON-SURGICAL TREATMENT METHODS - A LITERATURE REVIEW
Introduction: Obesity, a global health crisis, is a leading risk factor for chronic diseases like diabetes and cardiovascular disease. Its prevalence has more than doubled since 1990, straining healthcare systems. Management involves primary prevention (lifestyle interventions), secondary prevention (early detection and treatment), and tertiary prevention (managing established obesity via lifestyle changes, pharmacotherapy, or bariatric surgery). This review focuses on non-invasive treatment methods for obesity. Materials and methods: This review was conducted using PubMed and Google Scholar databases, focusing on recent systematic reviews, meta-analyses, and original research on non-surgical obesity treatments. Keywords included obesity, diet, exercise, pharmacotherapy, and education. Results: Recent findings suggest that combining reduced calorie intake with limited carbohydrate consumption can lead to more effective weight loss. Diets high in protein, particularly those containing whey, are beneficial for maintaining muscle mass during weight reduction. Medications such as GLP-1 receptor agonists support weight loss and metabolic health. Regular physical activity enhances fat loss and cardiovascular performance. Additionally, patient-focused strategies are essential for improving adherence and ensuring long-term success in obesity treatment. Conclusions: Effective obesity treatment requires combining personalized nutrition plan, physical activity, and medications. Prioritizing muscle preservation, protein intake, patient education, and stigma reduction enhances adherence and supports long-term weight and metabolic health outcomes.
- Open Access
- 13 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60366
Comparison of first- and second-line imaging diagnostics (ultrasound + scintigraphy and PET + 4DCT) in visualizing parathyroid glands in primary hyperparathyroidism including ectopic foci
Introduction: Primary hyperparathyroidism is an endocrine disorder that causes disturbances in calcium and phosphorus metabolism in the human body. The most effective permanent treatment is surgery, which involves the removal of the affected gland. To locate such small glands, various imaging diagnostic methods, including nuclear medicine, are currently used. This study aims to review current imaging protocols for hyperparathyroid glands and compare first- and second-line methods, particularly in cases of ectopic foci. Material and methods: This review was prepared based on articles available on PubMed. The literature review was conducted using the following keywords: primary hyperparathyroidism, primary hyperparathyroidism imaging, primary hyperparathyroidism US, primary hyperparathyroidism MIBI, primary hyperparathyroidism PET/CT, primary hyperparathyroidism 4DCT, ectopic hyperparathyroidism imaging. The current state of knowledge: Primary hyperparathyroidism is a condition that can go unnoticed for an extended period. The diagnosis of the disease is based on laboratory tests, followed by the crucial step of locating the gland responsible for progressively causing damage to the body over time. Identifying the hyperactive gland is essential for performing a successful surgery and curing the patient. However, this often poses a significant challenge, due to the potential for ectopic gland locations. Summary: It is hard to unequivocally state the superiority of one imaging line over the other, as each has specific pros and cons in specific cases. However, in the case of ectopic foci, the 2nd imaging line shows promising results.
- 13 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60366
Open AccessComparison of first- and second-line imaging diagnostics (ultrasound + scintigraphy and PET + 4DCT) in visualizing parathyroid glands in primary hyperparathyroidism including ectopic foci
Introduction: Primary hyperparathyroidism is an endocrine disorder that causes disturbances in calcium and phosphorus metabolism in the human body. The most effective permanent treatment is surgery, which involves the removal of the affected gland. To locate such small glands, various imaging diagnostic methods, including nuclear medicine, are currently used. This study aims to review current imaging protocols for hyperparathyroid glands and compare first- and second-line methods, particularly in cases of ectopic foci. Material and methods: This review was prepared based on articles available on PubMed. The literature review was conducted using the following keywords: primary hyperparathyroidism, primary hyperparathyroidism imaging, primary hyperparathyroidism US, primary hyperparathyroidism MIBI, primary hyperparathyroidism PET/CT, primary hyperparathyroidism 4DCT, ectopic hyperparathyroidism imaging. The current state of knowledge: Primary hyperparathyroidism is a condition that can go unnoticed for an extended period. The diagnosis of the disease is based on laboratory tests, followed by the crucial step of locating the gland responsible for progressively causing damage to the body over time. Identifying the hyperactive gland is essential for performing a successful surgery and curing the patient. However, this often poses a significant challenge, due to the potential for ectopic gland locations. Summary: It is hard to unequivocally state the superiority of one imaging line over the other, as each has specific pros and cons in specific cases. However, in the case of ectopic foci, the 2nd imaging line shows promising results.
- Open Access
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 166-182
current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
Introduction Polycystic ovary syndrome (PCOS), first described by Stein and Leventhal in 1935, is one of the most prevalent endocrine system conditions affecting women of reproductive age. It affects between 6% and 13% of women and the majority of cases are identified between the ages of 20 and 30. Unfortunately, the disease is usually diagnosed only when bothersome symptoms such as hair loss, alopecia, acne, and infertility-related problems occur. Based on the Rotterdam criteria, four phenotypes of PCOS are distinguished. Aim of the study This review aims to present the current state of knowledge about possible treatment approaches, both non-pharmacological and pharmacological. Materials and methods The paper was created based on the Pubmed database. The literature was reviewed using the keywords: ”PCOS”, ”PCOS treatment” and “ PCOS medications “. The current state of knowledge Treatments for PCOS must be tailored to the specific needs of each patient. In the management of PCOS, special attention is paid to diet, physical activity, and restoration of the Gut Microbiome. Medications used in therapy are oral contraceptives and anti-androgens, insulin sensitizers, ovulation inducers, calcium and vitamin D supplements, statins, Glucagon-like-peptide-1 (GLP-1) agonists, inositols and interleukin 22 (IL-22) therapy. Summary Treatment options for menstrual irregularities and hirsutism are based on the clinical goals and preferences of the patient. The ideal would be causal treatment, but due to the ongoing lack of full understanding of the pathogenesis of the syndrome, is not entirely feasible. The ideal would be causal treatment, but due to the ongoing lack of full understanding of the pathogenesis of the syndrome, is not entirely feasible. The most important is a multimodal approach to treat comorbid conditions such as diabetes mellitus type 2, obesity, hyperlipidemia, depression, and infertility.
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 166-182
Open Accesscurrent possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
Introduction Polycystic ovary syndrome (PCOS), first described by Stein and Leventhal in 1935, is one of the most prevalent endocrine system conditions affecting women of reproductive age. It affects between 6% and 13% of women and the majority of cases are identified between the ages of 20 and 30. Unfortunately, the disease is usually diagnosed only when bothersome symptoms such as hair loss, alopecia, acne, and infertility-related problems occur. Based on the Rotterdam criteria, four phenotypes of PCOS are distinguished. Aim of the study This review aims to present the current state of knowledge about possible treatment approaches, both non-pharmacological and pharmacological. Materials and methods The paper was created based on the Pubmed database. The literature was reviewed using the keywords: ”PCOS”, ”PCOS treatment” and “ PCOS medications “. The current state of knowledge Treatments for PCOS must be tailored to the specific needs of each patient. In the management of PCOS, special attention is paid to diet, physical activity, and restoration of the Gut Microbiome. Medications used in therapy are oral contraceptives and anti-androgens, insulin sensitizers, ovulation inducers, calcium and vitamin D supplements, statins, Glucagon-like-peptide-1 (GLP-1) agonists, inositols and interleukin 22 (IL-22) therapy. Summary Treatment options for menstrual irregularities and hirsutism are based on the clinical goals and preferences of the patient. The ideal would be causal treatment, but due to the ongoing lack of full understanding of the pathogenesis of the syndrome, is not entirely feasible. The ideal would be causal treatment, but due to the ongoing lack of full understanding of the pathogenesis of the syndrome, is not entirely feasible. The most important is a multimodal approach to treat comorbid conditions such as diabetes mellitus type 2, obesity, hyperlipidemia, depression, and infertility.
- Open Access
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 220-234
The multimodal approach to obesity treatment – current pharmacological and surgical methods and lifestyle changes
Introduction Obesity is one of the major health problems of today’s population and is defined as a body mass index ≥ 30 kg/m2. It is known that obesity may cause many complications such as type 2 diabetes, cardiovascular disease, osteoarthritis, obstructive sleep, apnoea, and several cancers. The only effective treatment of obesity can be pharmacological or surgical, especially when a years-long attempt to change habits has had no effects. Aim of the study This review aims to present the current state of knowledge about non-pharmacological and pharmacological obesity treatment methods. Materials and methods The paper was created based on the Pubmed database. The literature was reviewed using the keywords: ”obesity”, ”obesity treatment”, “ obesity lifestyle changes”, “obesity medications” and ”obesity surgery”. The current state of knowledge The treatment of obesity requires a multimodal approach to treatment, including the addition of anti-obesity medications or bariatric surgery, or both, to assist people in reaching and sustaining sufficient weight loss to meet treatment goals. The 3 principal components of a comprehensive lifestyle intervention are diet, physical activity, and behavioral therapy. Among available anti-obesity medications include orlistat, phentermine, topiramate, naltrexone, bupropion, liraglutide, and semaglutide. Summary The key challenge in the treatment of obesity is to maintain the effects obtained with multimodal therapy. Without proper motivation of patients and changes in eating and behavioral habits, it is impossible to achieve optimal results, therefore, in addition to medical interventions, more and more attention should be paid to psychological interventions.
- 14 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 220-234
Open AccessThe multimodal approach to obesity treatment – current pharmacological and surgical methods and lifestyle changes
Introduction Obesity is one of the major health problems of today’s population and is defined as a body mass index ≥ 30 kg/m2. It is known that obesity may cause many complications such as type 2 diabetes, cardiovascular disease, osteoarthritis, obstructive sleep, apnoea, and several cancers. The only effective treatment of obesity can be pharmacological or surgical, especially when a years-long attempt to change habits has had no effects. Aim of the study This review aims to present the current state of knowledge about non-pharmacological and pharmacological obesity treatment methods. Materials and methods The paper was created based on the Pubmed database. The literature was reviewed using the keywords: ”obesity”, ”obesity treatment”, “ obesity lifestyle changes”, “obesity medications” and ”obesity surgery”. The current state of knowledge The treatment of obesity requires a multimodal approach to treatment, including the addition of anti-obesity medications or bariatric surgery, or both, to assist people in reaching and sustaining sufficient weight loss to meet treatment goals. The 3 principal components of a comprehensive lifestyle intervention are diet, physical activity, and behavioral therapy. Among available anti-obesity medications include orlistat, phentermine, topiramate, naltrexone, bupropion, liraglutide, and semaglutide. Summary The key challenge in the treatment of obesity is to maintain the effects obtained with multimodal therapy. Without proper motivation of patients and changes in eating and behavioral habits, it is impossible to achieve optimal results, therefore, in addition to medical interventions, more and more attention should be paid to psychological interventions.
- 18 April 2019
- Published by Springer Nature
- p. 217-228
A Methodology for Trabecular Bone Microstructure Modelling Agreed with Three-Dimensional Bone Properties
- 18 April 2019
- Published by Springer Nature
- p. 217-228
A Methodology for Trabecular Bone Microstructure Modelling Agreed with Three-Dimensional Bone Properties